Hollsteen
← Alphabet

Cash and equivalents

Balance – as of period end · $B

QuartersFiscal years

$BCash and equivalents · Q1 2016: $15.1B · 10-Q 0001652044-16-000021 filed May 3, 2016Cash and equivalents · Q2 2016: $13.6B · 10-Q 0001652044-16-000032 filed Aug 4, 2016Cash and equivalents · Q3 2016: $9.4B · 10-Q 0001652044-16-000038 filed Nov 3, 2016Cash and equivalents · Q4 2016: $12.9B · 10-K 0001652044-17-000008 filed Feb 3, 2017Cash and equivalents · Q1 2017: $18.1B · 10-Q 0001652044-17-000014 filed May 2, 2017Cash and equivalents · Q2 2017: $15.7B · 10-Q 0001652044-17-000026 filed Jul 25, 2017Cash and equivalents · Q3 2017: $10.6B · 10-Q 0001652044-17-000042 filed Oct 27, 2017Cash and equivalents · Q4 2017: $10.7B · 10-K 0001652044-18-000007 filed Feb 6, 2018Cash and equivalents · Q1 2018: $12.7B · 10-Q 0001652044-18-000016 filed Apr 24, 2018Cash and equivalents · Q2 2018: $14.1B · 10-Q 0001652044-18-000027 filed Jul 24, 2018Cash and equivalents · Q3 2018: $13.4B · 10-Q 0001652044-18-000035 filed Oct 26, 2018Cash and equivalents · Q4 2018: $16.7B · 10-K 0001652044-19-000004 filed Feb 5, 2019Cash and equivalents · Q1 2019: $19.1B · 10-Q 0001652044-19-000015 filed Apr 30, 2019Cash and equivalents · Q2 2019: $16.6B · 10-Q 0001652044-19-000023 filed Jul 26, 2019Cash and equivalents · Q3 2019: $16.0B · 10-Q 0001652044-19-000032 filed Oct 29, 2019Cash and equivalents · Q4 2019: $18.5B · 10-K 0001652044-20-000008 filed Feb 4, 2020Cash and equivalents · Q1 2020: $19.6B · 10-Q 0001652044-20-000021 filed Apr 29, 2020Cash and equivalents · Q2 2020: $17.7B · 10-Q 0001652044-20-000032 filed Jul 31, 2020Cash and equivalents · Q3 2020: $20.1B · 10-Q 0001652044-20-000050 filed Oct 30, 2020Cash and equivalents · Q4 2020: $26.5B · 10-K 0001652044-21-000010 filed Feb 3, 2021Cash and equivalents · Q1 2021: $26.6B · 10-Q 0001652044-21-000020 filed Apr 28, 2021Cash and equivalents · Q2 2021: $23.6B · 10-Q 0001652044-21-000047 filed Jul 28, 2021Cash and equivalents · Q3 2021: $23.7B · 10-Q 0001652044-21-000057 filed Oct 27, 2021Cash and equivalents · Q4 2021: $20.9B · 10-K 0001652044-22-000019 filed Feb 2, 2022Cash and equivalents · Q1 2022: $20.9B · 10-Q 0001652044-22-000029 filed Apr 27, 2022Cash and equivalents · Q2 2022: $17.9B · 10-Q 0001652044-22-000071 filed Jul 27, 2022Cash and equivalents · Q3 2022: $22.0B · 10-Q 0001652044-22-000090 filed Oct 26, 2022Cash and equivalents · Q4 2022: $21.9B · 10-K 0001652044-23-000016 filed Feb 3, 2023Cash and equivalents · Q1 2023: $25.9B · 10-Q 0001652044-23-000045 filed Apr 26, 2023Cash and equivalents · Q2 2023: $25.9B · 10-Q 0001652044-23-000070 filed Jul 26, 2023Cash and equivalents · Q3 2023: $30.7B · 10-Q 0001652044-23-000094 filed Oct 25, 2023Cash and equivalents · Q4 2023: $24.0B · 10-K 0001652044-24-000022 filed Jan 31, 2024Cash and equivalents · Q1 2024: $24.5B · 10-Q 0001652044-24-000053 filed Apr 26, 2024Cash and equivalents · Q2 2024: $27.2B · 10-Q 0001652044-24-000079 filed Jul 24, 2024Cash and equivalents · Q3 2024: $20.0B · 10-Q 0001652044-24-000118 filed Oct 30, 2024Cash and equivalents · Q4 2024: $23.5B · 10-K 0001652044-25-000014 filed Feb 5, 2025Cash and equivalents · Q1 2025: $23.3B · 10-Q 0001652044-25-000043 filed Apr 25, 2025Cash and equivalents · Q2 2025: $21.0B · 10-Q 0001652044-25-000062 filed Jul 24, 2025Cash and equivalents · Q3 2025: $23.1B · 10-Q 0001652044-25-000091 filed Oct 30, 2025Cash and equivalents · Q4 2025: $30.7B · 10-K 0001652044-26-000018 filed Feb 5, 2026Cash and equivalents · Q1 2026: $38.1B · 10-Q 0001652044-26-000048 filed Apr 30, 2026Cash and equivalents · Q2 2026: $55.9B · 10-Q 0001652044-26-000071 filed Jul 23, 202617.755.915.1Q1 2016Q2 2026Q2 2020
$BCash and equivalents · Q2 2019: $16.6B · 10-Q 0001652044-19-000023 filed Jul 26, 2019Cash and equivalents · Q3 2019: $16.0B · 10-Q 0001652044-19-000032 filed Oct 29, 2019Cash and equivalents · Q4 2019: $18.5B · 10-K 0001652044-20-000008 filed Feb 4, 2020Cash and equivalents · Q1 2020: $19.6B · 10-Q 0001652044-20-000021 filed Apr 29, 2020Cash and equivalents · Q2 2020: $17.7B · 10-Q 0001652044-20-000032 filed Jul 31, 2020Cash and equivalents · Q3 2020: $20.1B · 10-Q 0001652044-20-000050 filed Oct 30, 2020Cash and equivalents · Q4 2020: $26.5B · 10-K 0001652044-21-000010 filed Feb 3, 2021Cash and equivalents · Q1 2021: $26.6B · 10-Q 0001652044-21-000020 filed Apr 28, 202117.726.616.6Q2 2019Q1 2021Q2 2020
Q2 2020
17.7$B
All values (42)
PeriodValue ($B)Status
Q2 202655.9reported
Q1 202638.1reported
Q4 202530.7reported
Q3 202523.1reported
Q2 202521.0reported
Q1 202523.3reported
Q4 202423.5reported
Q3 202420.0reported
Q2 202427.2reported
Q1 202424.5reported
Q4 202324.0reported
Q3 202330.7reported
Q2 202325.9reported
Q1 202325.9reported
Q4 202221.9reported
Q3 202222.0reported
Q2 202217.9reported
Q1 202220.9reported
Q4 202120.9reported
Q3 202123.7reported
Q2 202123.6reported
Q1 202126.6reported
Q4 202026.5reported
Q3 202020.1reported
Q2 202017.7reported
Q1 202019.6reported
Q4 201918.5reported
Q3 201916.0reported
Q2 201916.6reported
Q1 201919.1reported
Q4 201816.7reported
Q3 201813.4reported
Q2 201814.1reported
Q1 201812.7reported
Q4 201710.7reported
Q3 201710.6reported
Q2 201715.7reported
Q1 201718.1reported
Q4 201612.9reported
Q3 20169.4reported
Q2 201613.6reported
Q1 201615.1reported

CSV with all sources · Technical ID: cash

More metrics for Alphabet

Value drivers

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Sources & calculation
Value
$17.7B
Period
Q2 2020, ended Jun 30, 2020 · as of Jun 30, 2020 (balance as of date, not a sum)
Source
10-Q, filed Jul 31, 2020 · 0001652044-20-000032
Location
us-gaap:CashAndCashEquivalentsAtCarryingValue
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$17.7BJul 31, 202010-Q 0001652044-20-000032reported · confidence 1. · current